Noninvasive serial electrophysiological testing using an implanted pacemaker for management of recurrent ventricular tachycardia.
An implanted multiprogrammable pacemaker capable of performing both premature and burst stimulation can be teamed with a special external programmer for noninvasive electrophysiological testing. Such studies, combined with indications from provocative pharmacologic tests, allowed us to formulate effective antiarrhythmic therapies for three patients suffering from post-infarction, recurrent sustained ventricular tachycardia.
D000368:Aged; D000638:Amiodarone / Q000627:therapeutic use; D004594:Electrophysiology; D006352:Heart Ventricles; D006801:Humans; D008297:Male; D008801:Mexiletine / Q000627:therapeutic use; D010138:Pacemaker, Artificial; D011405:Propafenone; D011427:Propiophenones / Q000627:therapeutic use; D012008:Recurrence; D012849:Sinoatrial Node / Q000503:physiopathology; D013610:Tachycardia / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*
D011427:Propiophenones; D008801:Mexiletine; D011405:Propafenone; D000638:Amiodarone